Abstract
Background: Dexamethasone cyclophosphamide (DC) pulse therapy seems to be emerging affordable modality of treatment in immunobullous disorders. The objective of this study was to describe the effectiveness of DC pulse therapy in immunobullous disease in our setting.
 Methods: This was a retrospective study carried out in the Department of Dermatology of a tertiary referral centre by reviewing the medical records of all the patients of immunobullous diseases receiving DC pulse therapy from January 2010 through January 2014.
 Results: There were a total of 10 patients of immunobullous disease receiving the therapy during above mentioned period (7- Pemphigus Vulgaris, 2- Pemhigus foliaceus, 1- Bullous Pemphigoid).There were 5 males and 5 females receiving the therapy, with the mean age of the diseased at presentation being 47.4 years. Out of 10 patients, 2 patients were lost to follow up after the 1st pulse. Out of 8 patients, 6 patients (75%) achieved clinical remission. The mean time to remission was 10.6months (Range: 3 months to 23 months). The major adverse effects seen during therapy were diabetes (50%) and leucopenia (20%).
 Conclusions: DC pulse therapy seems to be effective treatment modality in the management ofimmunobullous disorder in our setting with good safety profile.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of BP Koirala Institute of Health Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
